Cancer vaccines: the next immunotherapy frontier
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant, BMC Medicine
Immune responses three weeks after first dose of the BNT162b2 vaccine
Learning from prepandemic data to forecast viral escape
Predicting the antigenic evolution of SARS-COV-2 with deep learning
Frontiers Current Challenges in Vaccinology
Challenges and developments in universal vaccine design against SARS-CoV-2 variants
Frontiers The Omic Insights on Unfolding Saga of COVID-19
A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs
Browse Preprints - Authorea